These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28955092)

  • 1. Role of 5-ALA in improving extent of tumour resection in patients with Glioblastoma Multiforme.
    Waqas M; Khan I; Shamim MS
    J Pak Med Assoc; 2017 Oct; 67(10):1630-1632. PubMed ID: 28955092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation.
    Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL
    Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-aminolevulinic acid guidance during awake craniotomy to maximise extent of safe resection of glioblastoma multiforme.
    Corns R; Mukherjee S; Johansen A; Sivakumar G
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26177997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
    Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
    Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
    Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
    J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery.
    Cordova JS; Gurbani SS; Holder CA; Olson JJ; Schreibmann E; Shi R; Guo Y; Shu HK; Shim H; Hadjipanayis CG
    Mol Imaging Biol; 2016 Jun; 18(3):454-62. PubMed ID: 26463215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma.
    Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C
    Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathological analysis of the surgical margins of resected glioblastomas excised using photodynamic visualization with both 5-aminolevulinic acid and fluorescein sodium.
    Yano H; Nakayama N; Ohe N; Miwa K; Shinoda J; Iwama T
    J Neurooncol; 2017 Jun; 133(2):389-397. PubMed ID: 28432590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
    Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
    Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results.
    Tykocki T; Michalik R; Bonicki W; Nauman P
    Neurol Neurochir Pol; 2012; 46(1):47-51. PubMed ID: 22426762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Intra-operative MRI (iMRI) in Improving Extent of Resection and Survival in Patients with Glioblastoma Multiforme.
    Khan I; Waqas M; Shamim MS
    J Pak Med Assoc; 2017 Jul; 67(7):1121-1123. PubMed ID: 28770902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminolevulinic acid (ALA)-protoporphyrin IX fluorescence guided tumour resection. Part 1: Clinical, radiological and pathological studies.
    Colditz MJ; Jeffree RL
    J Clin Neurosci; 2012 Nov; 19(11):1471-4. PubMed ID: 22959448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-ALA fluorescence-assisted surgery in pediatric brain tumors: report of three cases and review of the literature.
    Barbagallo GM; Certo F; Heiss K; Albanese V
    Br J Neurosurg; 2014 Dec; 28(6):750-4. PubMed ID: 24799277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current surgical management of glioblastoma.
    Hentschel SJ; Lang FF
    Cancer J; 2003; 9(2):113-25. PubMed ID: 12784877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for Glioblastoma: Impact of the Combined Use of 5-Aminolevulinic Acid and Intraoperative MRI on Extent of Resection and Survival.
    Coburger J; Hagel V; Wirtz CR; König R
    PLoS One; 2015; 10(6):e0131872. PubMed ID: 26115409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Letter to the Editor. 5-ALA fluorescence-guided surgery as standard of care in the resection of GBM.
    Foo JQX; Zheng Y
    J Neurosurg; 2024 Jun; 140(6):1816-1817. PubMed ID: 38364225
    [No Abstract]   [Full Text] [Related]  

  • 18. Neurosurgical oncology: advances in operative technologies and adjuncts.
    D'Amico RS; Kennedy BC; Bruce JN
    J Neurooncol; 2014 Sep; 119(3):451-63. PubMed ID: 24969924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgery of high-grade gliomas guided by fluorescence: a retrospective study of 22 patients].
    Jacquesson T; Ducray F; Maucort-Boulch D; Armoiry X; Louis-Tisserand G; Mbaye M; Pelissou-Guyotat I; Guyotat J
    Neurochirurgie; 2013 Feb; 59(1):9-16. PubMed ID: 23318102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit.
    Sage W; Guilfoyle M; Luney C; Young A; Sinha R; Sgubin D; McAbee JH; Ma R; Jefferies S; Jena R; Harris F; Allinson K; Matys T; Qian W; Santarius T; Price S; Watts C
    J Neurooncol; 2018 Jan; 136(2):273-280. PubMed ID: 29139095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.